Long intergenic noncoding RNAs (lincRNAs) are not fully characterized in disease, although many are involved in controlling differentiation. We discovered and sequenced a novel 4.4 kb human lincRNA called linc-9432 in pterygium, an ocular disease characterized by a wedge lesion. This transcript inhibited differentiation-induced cell death, promoted expression of stem cell markers, and decreased expression of epithelial and mesenchymal differentiation markers. This lincRNA regulated 30 differentiation-related genes in transcriptome analysis and 17/30 gene products were known to be directly associated in a network. When the lincRNA was silenced with pooled siRNA, the levels of these transcripts decreased in accordance with their predicted binding affinity for the lincRNA. TBC1D8B had the strongest affinity, interacting in-vitro at positions 269-292 within TBC1D8B.
Pterygium is an ocular surface disease characterized by fibrovascular proliferation forming a wedge-shaped lesion growing on the eye [1] . It is associated with significant healthcare costs and morbidity and estimated to affect up to 200 million people in the world [2] . Although it is associated with ultraviolet or sunlight exposure, the details of its pathogenesis are essentially unknown [3] . Currently, the only definitive treatment is surgical excision, but this can be followed by post excision recurrences [4] .
The mammalian genome includes the sequences of thousands of nonprotein coding transcripts, including a group of > 2000 bp long noncoding RNA termed long intergenic noncoding RNAs (lincRNAs) [5] . This class of lincRNAs is increasingly investigated in recent years, especially in the context of diseases [6] . A few mechanisms of how lincRNAs affect gene function have been proposed [7] . This includes homologous pairing of lincRNA with the target mRNA, the formation of RNA-DNA hybrids or chromatin interactions, RNA structure-mediated interactions and mediating linkage of nucleic acid binding proteins [7] . LincRNAs have been linked to disease-like cancer through alteration of global gene expression [8] . Developmental programming differentiation and pluripotency are some processes known to be regulated by lincRNAs [9] .
Interestingly, abnormal stem cell property and differentiation defects are also known features in the pathology of pterygium [10] [11] [12] . It has been suggested that UV radiation results in hyperactivity of limbal stem cells, triggering clonal cell expansion, proliferation and invasion of the cornea. Alternatively, limbal stem cell deficiency results in a breakdown of the conjunctiva-cornea barrier and invasion of conjunctiva cells toward the cornea [13] . Infiltration of fibroblasts is increased in pterygium [14] , and molecular disturbances suggesting differentiation defects, have been reported by at least four studies [13, [15] [16] [17] . Cell cycle defects have been implicated through the study of p27 [10] [11] [12] , p53 [18] [19] [20] , and Ras [21] . When cells differentiate terminally, they tend to divide less (less proliferative), become less clonogenic and may even undergo programmed or developmental cell death [22] . Regardless of the importance of interactions between cell types, the fibroblasts play a central role in this condition because of the elaboration of the 'fleshy' extracellular matrix in some cases, and the production of matrix metalloproteinases (MMPs) in all cases. MMPs are critical for the destruction and invasion of the pterygium into the subepithelial Bowman's layer of the cornea. Therefore, if differentiation or proliferation of fibroblasts or precursors becomes abnormal, one can envision the progression of this disease.
We postulate that the fibroblast dysfunction in pterygium may be regulated by lincRNAs. Therefore, we aim to determine if lincRNAs are differentially expressed in pterygium when compared to normal conjunctival tissues from the same eyes of patients who had undergone pterygium excision surgery. A second aim was to determine the role of differentially regulated lincRNAs in cell proliferation using a siRNA-based screen. Third, we aim to establish a mechanistic role for lincRNA in pteyrgium fibroblasts that can explain the disease, beginning with bioinformatic screening approaches but verifying with conventional cellular and in vitro studies.
Materials and methods

Patients
The tissues used in this study were from patients in the Pterygium Aetiology and Conjunctival Evaluation Study, an ongoing study at the Singapore National Eye Center. The protocol was approved by the centralized institutional review board of Singhealth services, and written informed consent was obtained from all patients. The study complied with the Tenets of Helsinki. The surgical excision and collection of the samples, as well as the demographics of the patients, have been previously described [1] . Briefly, paired pterygium and uninvolved conjunctival tissue (from the superior temporal conjunctiva) were procured from the same patient eye. All pterygia were nasal.
Extraction of RNA
Surgical specimens in RNAlater (Qiagen, Germantown, MD, USA) were frozen at À80°C. The tissues were thawed to room temperature. The RNAlater was aspirated and replaced with 100 lL of TRIzol (Invitrogen, Carlsbad, CA, USA), then refrozen with liquid nitrogen. When frozen, the tissues were ground with Kontes pellet pestles, and this procedure was repeated until the samples were homogenous. Further homogenization was performed using an 18G needle and syringe, and topped up to 500 lL with TRIzol. We added 100 lL of chloroform, vortexed, and incubated for 2-3 min at room temperature. After centrifuging at 12 000 g (~10 000 r.p.m.) at 4°C for 15 min, the clear fraction on top was carefully pipetted into a new tube. An equal volume of 70% ethanol was added, and the mixture transferred to an RNeasy column (Qiagen) from the RNA isolation kit. The subsequent additions of DNase and wash buffers, along with the elution step were performed according to the manufacturer's instructions (Qiagen).
Quality control of RNA and microarray workflow
The quality of RNA was evaluated using the Agilent RNA 6000 Nano Chip (Agilent Technologies, Santa Clara, CA, USA). All samples evaluated for microarray experiments had RIN 7.0 and above. After cRNA labeling, the yield was more than 2.0 lg in all samples.
The microarray analysis was performed using the Agilent SurePrint G3 Gene Expression 8 9 60 K (ID: G4851-60510) single-color microarray, which included probes to over 40 000 transcripts, including noncoding RNAs such as lincRNAs identified in publicly available human reference catalogs (such as the Broad Institute database).
We labeled 40 ng of total RNA with the Low Input Quick Amp Labeling Kit, one color (Agilent Technologies, Version 6.5). Briefly, the RNA was converted into double-stranded cDNA by priming with an oligo-dT primer containing the recognition site for T7 RNA polymerase. In vitro transcription with T7 RNA polymerase was used to produce cyanine 3-CTP-labeled cRNA. We hybridized 600 ng of labeled cRNA onto the above microarray for 17 h at 65°C at 10 r.p.m. in an Agilent hybridization oven. After hybridization, the microarray slide was washed in Gene Expression Wash Buffer 1 for 1 min at room temperature and in Gene Expression Wash Buffer 2 at 37°C for 1 min before scanning on the Agilent High-Resolution Microarray Scanner (C-model). Raw signal data were extracted from the tiff image with AGILENT FEATURE EXTRACTION Software (V10.7.1.1; Agilent Technologies, Santa Clara, CA, USA). The workflow was performed by Molecular Genomics Pte Ltd, Singapore.
Microarray data analysis
The data from the tissue study have been uploaded and are publicly available (NCBI GEO GSE83627). The threshold of the raw signals was set to 1.0. Data were transformed to log 2 values. Per-chip normalization was performed by percentile shift to the 75th percentile. Per gene normalization was performed by baseline transformation to the median of all samples. A box plot of normalized data for the samples showed a similar distribution in each sample. Principal component analysis (PCA) of the normalized data was performed, and the 3D scatter plot, in the case of the pterygium tissue experiment, showed separation of the points representing pterygium tissue from the points representing conjunctival tissue.
Subsequent quality control on the probe set to remove faulty or suspicious probes was done by filtering on flags (probes flagged as 'not detected' and 'compromised') and filtering on expression [removal of probes with very low raw signal intensity (< 20) ]. After this quality control step, 27 714 features remained.
Using a threshold of at least twofold dysregulation in pterygium/conjunctival samples with a P < 0.05, there were 460 probes of interest. Using the key terms 'lincRNA,' 'non-coding,' and 'miscRNA' and some predicted mRNA with 'XR' naming in GenBank to search the annotation of the probes of interest yielded 54 probes against nc-RNA (Table S1 ). We noted that the lincRNA probes (A_19 series) were designed with the Broad Institute's first release of its lincRNA database. Many of these lincRNAs did not have annotations, and the only known information was their genomic location. We found that 44 distinct nc-RNAs could be identified by these probes. We proceeded to validate the regulation of these 44 nc-RNAs using reverse transcription real-time (RT) quantitative on more paired pterygium/conjunctiva samples from other patients as described below. The probes that had been validated successfully are shown in Table S5 .
For profiling the genes dysregulated by Linc-9432 silencing, four pairs of primary pterygium fibroblast cells treated for 48 h with three different sequences of 21 nM pooled siRNA targeting Linc-9432 or a nonspecific control oligonucleotide were analyzed. Using microarray preparation and the analysis techniques described above, the Agilent SurePrint G3 Gene Expression 8 9 60 K microarray (ID: G6851-60510) was used for this experiment, and the expression of dysregulated genes was verified using RT-qPCR on additional samples.
RT-qPCR
Real-time qPCR was performed as previously described [1] . Briefly, 1 lg of total RNA was used per sample. For reverse transcription, the SuperScript III reverse transcriptase/RNaseOUT Enzyme Mix was used in combination with random hexamers.
For PCR, we used the SYBR green system with the LightCycler 480 instrument (Roche, South San Francisco, CA, USA). The PCR primers used are shown in Table S6 . Briefly, pre-incubation at 95°C for 5 min was used to activate FastStartTaq polymerase and denature cDNA, following which amplification was done for up to 45 cycles [10 s at 95°C (denaturation), 15 s at 55°C (annealing), and 20 s at 72°C (extension)].
The glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene was used as an endogenous reference for each reaction to correct for differences in the amount of total RNA added. Calibrator-normalized relative quantification (the DDCt method) without standard curves was performed to determine the fold changes compared to experimental controls.
Real-time qPCR was performed for 40 preselected cell cycling (cell division)-related genes in the PCR Array (Qiagen). In four independent experiments, pooled siRNA against Linc-9432 was added to PDFs (see 'RNA interference' section below). After cell lysis, RNA was collected 24 and 48 h after transfection, then subjected to RT-qPCR. In addition, PCR was performed with custom primers against E2F1, CCNG1, CCNB2 and CCNC under similar conditions but did not yield any significant effects due to Linc-9432 silencing (data not shown).
Cell culture
Fibroblast cells were cultured from pterygium patients using the explant method [1] . Briefly, cell culturing was performed with Dulbecco's modified Eagle's medium (DMEM)/F12 (Invitrogen) in 10% FBS (Invitrogen). Cells were cultured in a humid incubator at 5% CO 2 at 37°C, and the medium was changed every 48 h. Passages 2-5 were used in subsequent experiments. Various cell lines were obtained from ATCC and cultured according to the instructions provided.
RNA interference
Custom-designed siRNA (Silencer Select Library siRNA; Invitrogen) was used to target each of the significantly dysregulated lincRNAs. Three siRNA sequences were designed for each lincRNA to minimize off-target effects using a custom siRNA design service (Life Technologies, Carlsbad, CA, USA). The sequences designed are shown in Table S7 .
The transfection procedure was performed as recommended by the manufacturer (http://www.invitrogen.com/ site/us/en/home/References/protocols/cell-culture/transfectionprotocol/rnaimax-reverse-transfections-lipofectamine.html).
In preliminary experiments, the transfection efficiency was optimized using siRNA in different concentrations with different amounts of transfection reagent. The amount of transcript silencing by siRNA against GAPDH was assessed by determining the GAPDH protein concentration using the KDalert GAPDH assay (Life Technologies). Briefly, 24 h after the suspended pterygium fibroblasts were incubated with the transfection reagent RNAiMAX, cells were lysed. A standard curve of known amounts of GAPDH enzyme was constructed. The optimal ratio of transfection reagent to siRNA (producing the maximal amount of GAPDH silencing) was 0.3 lL of reagent to 2 pM siRNA, and this ratio was used in subsequent experiments.
Cell impedance assay
For the functional screening of the lincRNAs, the three siRNA were pooled at a concentration of 7 nM each. Negative control oligonucleotide (nonhuman-targeting siRNA) was used at a concentration of 21 nM. Two different negative control sequences were used.
The cell impedance assay was performed as previously described [23] . Briefly, it was a 96-well assay performed with the xCELLigence system (Roche). Each well of the E-Plates contained 50 lL of DMEM/F12 (with 10% FBS), 30 lL of PDF suspension at 3000 cells per well, and 20 lL of transfection reagent and siRNA in Opti-MEM culture medium (Invitrogen). Five replicates for each condition (lincRNA target or control) were used, as well as nontransfected controls. Cells were incubated in the above culture conditions, and cell impedance, expressed as cell index, was monitored every 15 min for up to 72 h.
Cell proliferation (BrdU) assay
Cell proliferation was analyzed using the BrdU flow kit (Becton-Dickenson Biosciences, Franklin Lakes, NJ, USA). Cultured PDFs reverse-transfected with pooled siRNA targeting Linc-9432 or a nonspecific control oligonucleotide were seeded onto a six-well plate and allowed to attach overnight. BrdU reagent was added to the cells 48 h later, and they were incubated for 24 h at 37°C. The cells were fixed with Cytofix/Cytoperm buffer and permeabilized using Permeabilization Buffer Plus. After refixation of the cells, DNase was added to expose the incorporated BrdU. The cells were re-incubated for 30 min, washed, and stained with FITC-conjugated anti-BrdU antibody, followed by 7-AAD staining for total DNA. Cells were analyzed on the FACSVerse flow cytometer (Becton-Dickenson Biosciences).
Illumina deep sequencing
RNA samples were prepared using the SureSelect Strand Specific RNA Library Prep Kit. Total RNA was extracted from three cultured primary PDF cell lines. The RNA sample was purified, denatured, and chemically fragmented. For first-strand cDNA synthesis, a mixture of first-strand master mix and actinomycin D were added. RNA Seq Second Strand and End Repair master mix was added to the sample to initiate second-strand cDNA synthesis. The cDNA was purified using AMPure XP beads. The 3 0 ends of the cDNA were adenylated using RNA Seq dA Tailing master mix. The SureSelect Ligation master mix and SureSelect Oligo Adaptor Mix were added to the cDNA, and the adaptor-ligated cDNA was purified. The cDNA was amplified by PCR using the RNA Seq PCR Master Mix, uracil-DNA glycosylase (UDG), SureSelect Primer (forward primer), and RNA Seq ILM Reverse PCR Primer. After assessment of DNA integrity with a 2100 Bioanalyzer DNA 1000 Assay, the cDNA library was paired-end sequenced using the Illumina HiSeq 2000. The Illumina HiSeq 2000 generated up to 200 Gb of sequence per run with read lengths of 2 9 100 bp (forward and reverse). To align the next-generation sequencing results to the human genome, TopHat2 aligner version 2.0.9 (http://tophat.cbcb.umd.edu) was used with the NCBI Reference Sequence (RefSeq) database's hg19 RefSeq (ftp:// ftp.ncbi.nlm.nih.gov/refseq/H_sapiens/H_sapiens/) as well as the Illumina iGenomes' annotation (http://support.illu mina.com/sequencing/sequencing_software/igenome.ilmn). The stranded setting was used for TopHat2 analysis.
Gene expression quantification was performed using Cufflinks (http://cufflinks.cbcb.umd.edu) with stranded information and annotation from iGenomes (http://support. illumina.com/sequencing/sequencing_software/igenome.ilmn) and RefSeq (ftp://ftp.ncbi.nlm.nih.gov/refseq/H_sapiens/H_ sapiens/GFF).
Conventional capillary sequencing and rapid amplification of c-DNA ends
To delineate the full sequence of linc-9432, conventional PCR was performed using primers designed with the PRIMER3 software (Whitehead Institute for Biomedical Research, Cambridge, MA, USA). The primers used in this procedure are listed in Table S2 .
Rapid amplification of cDNA ends (RACE) was used to obtain the 5 0 and 3 0 ends of Linc-9432. The cycling of temperatures used protocols on the LightCycler 480. Reactions were performed on 384-well plates, and the temperature was cycled between 45 and 97°C using the standard ramp rate. The calculation of melt curves uses the manufacturer's (Roche) software. The melt curves were then normalized to the same starting (highest) fluorescence and lowest fluorescence levels for comparison.
Bioinformatics
For the sequencing of linc-9432, multiple sequence alignments of the sequenced fragments were done with NCBI BLAST using the human chromosome database. Pathway analysis was performed using the STRING web tool (http://string-db.org/) [24] . This tool illustrates known relationships between a specified list of proteins, including evidence from direct binding as well as functional associations. The STRING resource currently covers 9 643 763 proteins obtained from 2031 organisms. Design of various siRNA sequences was done as a service of Life Technologies.
To identify genes related to differentiation in the list of genes dysregulated by Linc-9432 silencing, the words 'differentiation' or 'development' were used to search the Gene Ontology (GO) classifications annotated in the microarray experiment results, under the headings of 'biological process,' 'cellular component,' and 'molecular function.' The GO list had been exported from the online tool DAVID (https://david.ncifcrf.gov/).
Noncovalent interactions between various transcripts of differentiation-related proteins and Linc-9432 were predicted computationally based on known sequence and structure information. For each transcript, potential binding sites were discovered using Freiburg RNA tools (http:// rna.informatik.uni-freiburg.de/) [25] . This tool measures binding energies based on sequence-structure alignments and predicts interactions. The search for factors that bind to the TBC1D8B transcript was performed on the web server REGRNA 1.0 [26] . This is a web resource that identifies exonic splicing enhancers and other motifs in mRNA and UTRs [26] .
Statistical analysis
Data were presented as mean fold change AE standard error of mean and analyzed using Student's two-tailed t test. P values < 0.05 were considered statistically significant.
Results and Discussion
Total RNA was extracted from pterygium and uninvolved conjunctiva tissues from the same eyes, and analyzed using the Agilent 8 9 60 K gene expression chip. According to this microarray analysis, linc-9432 was one of 44 lincRNAs dysregulated in pterygium tissue compared to uninvolved conjunctiva from the same eye, and the finding was validated using RTqPCR, which confirmed the dysregulation of 24 lincRNAs (16 upregulated and 8 downregulated; r = 0.58; Fig. 1A ). Additional RT-qPCR in 14 sets of pterygium/conjunctiva tissue confirmed that linc-9432 was upregulated 2.5 AE 0.83-fold (P = 0.046), and notably, was significantly upregulated in 11/14 patients (Fig. 1B) . Linc-9432, corresponding to A19_P00 809432, was one of the most highly upregulated lincRNAs in pterygium tissue.
To screen for potential functional relevance of the 24 dysregulated lincRNAs, we cultured primary fibroblasts from pterygium tissues (PDFs, passage 1-5; Fig. S1 ), silenced each lincRNA by reverse transfection with pooled siRNA, and measured cell impedance. Cell impedance screening is a noninvasive assay that quantifies the resistance of living cells on an E-Plate, and the reported cell index corresponds to cell numbers or cell areas [27] . We found that eight of the 24 lincRNAs markedly reduced fibroblast cell index, with A19_P00316552, A19_P00324774 and A19_P00809 432 producing the greatest effects ( Fig. 2A-D) . A19_P00809432 silencing reduced the cell index significantly, compared to the control, at 24-48 h after siRNA transfection (Fig. 2E) . Further experiments confirmed that the pooled siRNA reduced linc-9432 levels 0.15-0.18-fold by 24 h (P = 0.001) and 0.23-0.33-fold by 48 h (P = 0.07; Fig. S2A ), compared to nonspecific scrambled siRNA.
Next, we turned to evaluation of the transcripts in primary explant cultured PDFs instead of whole pterygium tissues. Deep RNA-seq (1.5 billion reads) was performed on pooled PDF RNA from three independent disease tissues (Table S1 ). Because many overlapping reads belonging to the putative lincRNA annotated as A_19_P00809432 were detected (122 reads), and because it is one of the functionally important lincRNAs, we fully sequenced this lincRNA by conventional sequencing (Table S2 ). Sequences at the 5 0 and 3 0 ends were determined using 5 0 and 3 0 RACE respectively. Figure 1C shows how the fragments were assembled into the novel 4.4-kb lincRNA. Upon alignment of the sequenced fragments using NCBI BLAST, we found that this lincRNA, which we called linc-9432, spanned chromosome 1q32.2, from nucleotides 207 534 352 to 207 538 767, was surprisingly shorter than the Agilent-annotated lincRNA A_19_P00809432 The linc-9432 we sequenced is therefore either novel or it may have been incorrectly annotated by Agilent. The sequence of linc-9432 is shown in Table S1 (NCBI accession: KX389700).
The changes observed in the functional screen may conceivably be related to the regulation of cell division rates, differential cell proliferation, or apoptotic cell death. However, when siRNA against linc-9432 was added, a few of the cell division-related genes were significantly affected (Table S3) . Cell cycle analysis in PDFs found that linc-9432 did not alter G1/S or G2/M progression in the steady state (Fig. S2B) or during cell cycle arrest with nocodazole (G2/M blocker) or aphidicolin (G1/S blocker; data not shown). There was no significant reduction in BrdU uptake (Fig. S2C) , suggesting that nucleotide intake and mitosis were not affected. The percentage of TUNEL-positive cells (data not shown) in nontransfected controls, cells transfected with scrambled siRNA, and cells transfected with siRNA targeting linc-9432 were 0.637 AE 0.045%, 1.107 AE 0.843%, and 1.093 AE 0.201%, respectively (P > 0.05), suggesting that linc-9432 did not regulate apoptosis.
To investigate in an unbiased way how linc-9432 regulates cell numbers, siRNA against linc-9432 was added to four pairs of PDFs, and global transcriptome analysis (NCBI GEO GSE83628) was performed. We found that the levels of transcripts from 103 genes (23 upregulated and 80 downregulated) were dysregulated at least twofold (P < 0.05) by linc-9432 silencing, as compared to scrambled siRNA. Based on GO classifications, differentiation-related genes were overrepresented among the dysregulated genes (Table S4) . RT-qPCR confirmed the expression changes in 30 of 32 of these differentiation-related genes (Fig. 3A) , with most of these being downregulated and only three upregulated. Exploration of the functional networks (using STRING) found that 17 of the 30 genes served in a common pathway (Fig. 3B) .
If linc-9432 regulates differentiation, it should affect markers of differentiation and stemness in a fetal cell line (CL-48), and indeed, during Linc-9432 silencing, markers of both epithelial (EpCAM) and mesenchymal differentiation (a-SMA and Vimentin) were upregulated while progenitor/stem-cell markers (CD133-2 and Oct-4) were downregulated (Fig. 3C) . From this data, we inferred that Linc-9432 is an inhibitor of differentiation. Loss of Linc-9432 may increase differentiation and decrease clonogenicity. Nonclonogenic cells stop dividing after a few generations in culture, reducing overall cell numbers and impedance.
To determine if linc-9432 binds to differentiationrelated transcripts, we computed the predicted binding energies of potential interactions, with a more negative binding energy suggesting greater interaction with Linc-9432. Among the differentiation-related transcripts, TBC1D8B was predicted to bind the most strongly with linc-9432, at À31.9 kcalÁmol À1 (Fig. 3D) .
The binding energies of these transcripts were also correlated with the fold changes in transcript levels in response to linc-9432 silencing (r = 0.72; Fig. 3D ), suggesting that binding energies reflect the interaction of various transcripts with linc-9432. The gene most downregulated by siRNA against linc-9432 was TBC1D8B (7.1 AE 0.04-fold, P = 0.001; Fig. 3A ), which encodes a Rab GTPase-associated trafficking-related protein. The region predicted to interact with linc-9432 is in the first exon, located 10 bp after the start of the protein-coding region (position 166; Fig. 4A ). To experimentally confirm that linc-9432 interacts with the TBC1D8B transcript, we synthesized an oligonucleotide (109 bp, 3116-3215) from linc-9432 (Fig. 4B) , another oligo of 97 bp containing the native TBC1D8B transcript (177-293; Fig. 4C ), and additional oligos with mutations in one of the potential binding sites on TBC1D8B (Fig. 4D-F) . The melting curve analysis (Fig. 4G) found that mutant 2 and especially mutant 3 had reduced affinity for the l-Linc-9432 sequence, compared to wild-type TBC1D8B. Control experiments using a longer TBC1D8B segment with the mutation site upstream of the predicted interacting regions, shown in Fig. 4A , did not induce a drop in fluorescence (data not shown). Linc-9432 bound to its own complementary sequence (positive control) as expected, with high fluorescence levels between 45 and 90°C (data not shown).
The experiment above suggests that segment 269-292 of the TBC1D8B transcript (NM_017752.2) is the interaction site for linc-9432. How this affects TBC1D8B expression is unknown. A bioinformatics search (using RegRNA 1.0) suggested that a splicing factor (the exon enhancer ASF/SF2) binds to the GGAAG motif in this segment. More studies are required to determine if Linc-9432 competes with ASF/SF2 to regulate alternative splicing of TBC1D8B transcripts.
To determine whether the functional roles of our lincRNAs are limited to ocular fibroblasts or if they extend to other cells, we examined them in other cell lines. We found that three of the lincRNAs [A_19_P00316552, A_19_P00324774, A_19_P00809432 (linc-9432)] affected impedance in a variety of physiological and pathological cell lines ( (Fig. S3B) , suggesting a widespread role for linc-9432. This is the first report of lincRNAs affecting nonimmune, noncancerous cells in humans. This study has a few limitations. A limitation of microarray studies in tissues is that a variety of cell types are included, making it harder to interpret changes in transcripts. We were unable to study the potential rescue effect of expressing the lincRNA in cultured cells since over-expression had resulted in a very uncontrolled and high rate of this transcript being produced, leading to extensive cell death.
Previous studies have highlighted the central role of fibroblasts in pterygium [13] , but molecular disturbances that alter fibroblast behavior are poorly understood in this disease. LincRNAs interact with target genes through various ways in nonocular contexts [7] , and in pterygium, we found that excessive levels of linc-9432 bound to TBC1D8B and upregulated a network of differentiation-related factors (Fig. 3A) to inhibit terminal differentiation. Nondifferentiating fibroblasts may remain in a progenitor state, proliferate, and secrete abundant extracellular matrix proteins to form the pterygium stroma [28] . Future studies will need to address the effects of linc-9432 in the development of organs and whole organisms.
In conclusion, based on the 60-bp sequence of a previously annotated lincRNA that is upregulated in pterygium, we discovered, sequenced and investigated the cellular effect of a novel lincRNA. This lincRNA regulates the levels of differentiation-related transcripts in fibroblasts, and play similar roles in a variety of other human cell types. 
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